USD 8.78
(-3.3%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 62.97 Million USD | -2.33% |
2022 | 64.47 Million USD | -14.86% |
2021 | 75.73 Million USD | 122.67% |
2020 | 34.01 Million USD | -12.2% |
2019 | 38.73 Million USD | 64.12% |
2018 | 23.6 Million USD | -12.68% |
2017 | 27.03 Million USD | 35.39% |
2016 | 19.96 Million USD | -10.25% |
2015 | 22.24 Million USD | -13.69% |
2014 | 25.77 Million USD | 44.4% |
2013 | 17.84 Million USD | 66.98% |
2012 | 10.68 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 65.63 Million USD | 0.75% |
2024 Q1 | 65.14 Million USD | 3.45% |
2023 Q1 | 61.95 Million USD | -3.91% |
2023 FY | 62.97 Million USD | -2.33% |
2023 Q4 | 62.97 Million USD | 5.35% |
2023 Q2 | 59.24 Million USD | -4.37% |
2023 Q3 | 59.77 Million USD | 0.89% |
2022 Q4 | 64.47 Million USD | -4.71% |
2022 FY | 64.47 Million USD | -14.86% |
2022 Q2 | 71.75 Million USD | -1.95% |
2022 Q1 | 73.18 Million USD | -3.36% |
2022 Q3 | 67.66 Million USD | -5.7% |
2021 Q2 | 74.48 Million USD | -2.11% |
2021 Q1 | 76.09 Million USD | 123.72% |
2021 FY | 75.73 Million USD | 122.67% |
2021 Q3 | 74.08 Million USD | -0.54% |
2021 Q4 | 75.73 Million USD | 2.23% |
2020 Q4 | 34.01 Million USD | -1.08% |
2020 Q2 | 35.19 Million USD | 0.47% |
2020 Q3 | 34.38 Million USD | -2.31% |
2020 Q1 | 35.03 Million USD | -9.56% |
2020 FY | 34.01 Million USD | -12.2% |
2019 Q3 | 40.84 Million USD | -6.09% |
2019 FY | 38.73 Million USD | 64.12% |
2019 Q2 | 43.49 Million USD | 78.99% |
2019 Q1 | 24.29 Million USD | 2.95% |
2019 Q4 | 38.73 Million USD | -5.16% |
2018 FY | 23.6 Million USD | -12.68% |
2018 Q4 | 23.6 Million USD | 1.47% |
2018 Q3 | 23.26 Million USD | -2.34% |
2018 Q2 | 23.81 Million USD | -7.27% |
2018 Q1 | 25.68 Million USD | -4.98% |
2017 FY | 27.03 Million USD | 35.39% |
2017 Q1 | 18.97 Million USD | -4.94% |
2017 Q2 | 17.43 Million USD | -8.12% |
2017 Q3 | 16.31 Million USD | -6.41% |
2017 Q4 | 27.03 Million USD | 65.64% |
2016 Q1 | 22.25 Million USD | 0.07% |
2016 FY | 19.96 Million USD | -10.25% |
2016 Q4 | 19.96 Million USD | -6.13% |
2016 Q3 | 21.26 Million USD | -0.09% |
2016 Q2 | 21.28 Million USD | -4.37% |
2015 Q3 | 22.57 Million USD | -3.03% |
2015 Q2 | 23.28 Million USD | -75.53% |
2015 Q1 | 95.17 Million USD | 269.3% |
2015 FY | 22.24 Million USD | -13.69% |
2015 Q4 | 22.24 Million USD | -1.48% |
2014 Q4 | 25.77 Million USD | -5.37% |
2014 Q2 | 30.34 Million USD | 1.14% |
2014 FY | 25.77 Million USD | 44.4% |
2014 Q3 | 27.23 Million USD | -10.26% |
2014 Q1 | 30 Million USD | 68.12% |
2013 Q2 | 12.11 Million USD | 10.96% |
2013 Q1 | 10.91 Million USD | 2.16% |
2013 Q3 | 12.16 Million USD | 0.39% |
2013 Q4 | 17.84 Million USD | 46.74% |
2013 FY | 17.84 Million USD | 66.98% |
2012 Q3 | - USD | 0.0% |
2012 FY | 10.68 Million USD | 0.0% |
2012 Q4 | 10.68 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 31.36 Million USD | -100.765% |
Cerus Corporation | 197.74 Million USD | 68.155% |
Envoy Medical, Inc. | 7.64 Million USD | -724.241% |
electroCore, Inc. | 16.38 Million USD | -284.28% |
Helius Medical Technologies, Inc. | 7.69 Million USD | -718.669% |
IceCure Medical Ltd | 16.41 Million USD | -283.742% |
Inogen, Inc. | 326.19 Million USD | 80.695% |
OrthoPediatrics Corp. | 449.58 Million USD | 85.993% |
Lucid Diagnostics Inc. | 27.27 Million USD | -130.92% |
Monogram Orthopaedics, Inc. | 16.57 Million USD | -279.83% |
MaxCyte, Inc. | 268.27 Million USD | 76.527% |
NeuroOne Medical Technologies Corporation | 8.09 Million USD | -677.69% |
Nexalin Technology, Inc. | 3.63 Million USD | -1633.851% |
Orthofix Medical Inc. | 925.31 Million USD | 93.195% |
PAVmed Inc | 33.11 Million USD | -90.139% |
Rapid Micro Biosystems, Inc. | 143.45 Million USD | 56.102% |
RxSight, Inc. | 182.55 Million USD | 65.504% |
Sight Sciences, Inc. | 166.65 Million USD | 62.213% |
SI-BONE, Inc. | 230.42 Million USD | 72.671% |
TELA Bio, Inc. | 78.04 Million USD | 19.316% |
Treace Medical Concepts, Inc. | 251.9 Million USD | 75.002% |
Vivos Therapeutics, Inc. | 10.73 Million USD | -486.878% |
Acutus Medical, Inc. | 53.96 Million USD | -16.701% |
Talis Biomedical Corporation | 98.34 Million USD | 35.965% |
Spectral AI, Inc. | 10.69 Million USD | -488.964% |
Nano-X Imaging Ltd. | 218.64 Million USD | 71.199% |
CVRx, Inc. | 115.22 Million USD | 45.351% |
DIH Holding US, Inc. Warrants | 58.66 Million USD | -7.349% |
PetVivo Holdings, Inc. | 3.11 Million USD | -1921.409% |
Bioventus Inc. | 810.91 Million USD | 92.234% |
Venus Concept Inc. | 93.65 Million USD | 32.761% |
TriSalus Life Sciences, Inc. | 25.72 Million USD | -144.789% |
LivaNova PLC | 2.42 Billion USD | 97.408% |
908 Devices Inc. | 202.98 Million USD | 68.976% |
Alphatec Holdings, Inc. | 805.2 Million USD | 92.179% |
Nemaura Medical Inc. | 14.56 Million USD | -332.404% |
NeuroPace, Inc. | 107.65 Million USD | 41.504% |
LENSAR, Inc. | 69.58 Million USD | 9.503% |
Apyx Medical Corporation | 79.24 Million USD | 20.53% |
Cutera, Inc. | 346.29 Million USD | 81.815% |
STRATA Skin Sciences, Inc. | 42.01 Million USD | -49.876% |
BioSig Technologies, Inc. | 1.79 Million USD | -3402.336% |
Anika Therapeutics, Inc. | 270.63 Million USD | 76.732% |
ClearPoint Neuro, Inc. | 42.66 Million USD | -47.61% |
Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.335% |
Axonics, Inc. | 719.92 Million USD | 91.253% |
Outset Medical, Inc. | 313.8 Million USD | 79.933% |
IRIDEX Corporation | 34.43 Million USD | -82.867% |
PROCEPT BioRobotics Corporation | 404.71 Million USD | 84.44% |
IRadimed Corporation | 92.15 Million USD | 31.668% |
Tivic Health Systems, Inc. | 5.25 Million USD | -1098.553% |
INVO Bioscience, Inc. | 20.88 Million USD | -201.478% |
Telesis Bio, Inc. | 70.41 Million USD | 10.565% |
Viemed Healthcare, Inc. | 154.1 Million USD | 59.136% |
Varex Imaging Corporation | 1.24 Billion USD | 94.961% |
Quipt Home Medical Corp. | 247.4 Million USD | 74.547% |
Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -576.391% |
Pulmonx Corporation | 178.95 Million USD | 64.81% |
Dynatronics Corporation | 25.94 Million USD | -142.755% |
Modular Medical, Inc. | 13.8 Million USD | -356.087% |
ReShape Lifesciences Inc. | 10.72 Million USD | -487.042% |
Semler Scientific, Inc. | 78.06 Million USD | 19.334% |
InMode Ltd. | 863.28 Million USD | 92.706% |
Bruker Corporation | 4.24 Billion USD | 98.518% |
Cytosorbents Corporation | 53.26 Million USD | -18.234% |
DexCom, Inc. | 6.26 Billion USD | 98.995% |
Align Technology, Inc. | 6.08 Billion USD | 98.965% |
Viveve Medical, Inc. | 25.91 Million USD | -143.013% |
ZimVie Inc. | 1.2 Billion USD | 94.776% |
Movano Inc. | 9.42 Million USD | -568.422% |
Cytek Biosciences, Inc. | 497.66 Million USD | 87.347% |
Nexalin Technology, Inc. | 3.63 Million USD | -1633.851% |
DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -7.349% |
Tandem Diabetes Care, Inc. | 952.65 Million USD | 93.39% |
Profound Medical Corp. | 43.68 Million USD | -44.146% |
Insulet Corporation | 2.58 Billion USD | 97.567% |
enVVeno Medical Corporation | 48.63 Million USD | -29.479% |
Surmodics, Inc. | 185.73 Million USD | 66.095% |
iCAD, Inc. | 41.41 Million USD | -52.04% |
Nuwellis, Inc. | 9.77 Million USD | -544.545% |
Biotricity, Inc. | 5.94 Million USD | -959.666% |
iRhythm Technologies, Inc. | 433.14 Million USD | 85.462% |
Aethlon Medical, Inc. | 8.24 Million USD | -663.669% |
InspireMD, Inc. | 47.64 Million USD | -32.175% |
PAVmed Inc. | 33.11 Million USD | -90.139% |
BIOLASE, Inc. | 35.1 Million USD | -79.402% |
Beyond Air, Inc. | 56.96 Million USD | -10.553% |
FONAR Corporation | 214.24 Million USD | 70.608% |
AxoGen, Inc. | 196.82 Million USD | 68.006% |
Vivani Medical, Inc. | 45.79 Million USD | -37.502% |
Tactile Systems Technology, Inc. | 281.43 Million USD | 77.625% |
Inari Medical, Inc. | 674.23 Million USD | 90.66% |
UFP Technologies, Inc. | 404.13 Million USD | 84.418% |
QT Imaging Holdings, Inc. | 23.39 Million USD | -169.128% |
Heart Test Laboratories, Inc. | 9.5 Million USD | -562.646% |
Tenon Medical, Inc. | 6.34 Million USD | -892.467% |
Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -569.416% |
Co-Diagnostics, Inc. | 103.64 Million USD | 39.244% |
AdaptHealth Corp. | 4.61 Billion USD | 98.637% |
Sintx Technologies, Inc. | 15.36 Million USD | -309.841% |
NanoVibronix, Inc. | 6.67 Million USD | -843.542% |
Quanterix Corporation | 425.01 Million USD | 85.183% |
Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -576.391% |
Sensus Healthcare, Inc. | 53.72 Million USD | -17.207% |
Pacific Biosciences of California, Inc. | 1.74 Billion USD | 96.393% |
TransMedics Group, Inc. | 706.04 Million USD | 91.081% |
ReWalk Robotics Ltd. | 63.19 Million USD | 0.348% |
NeuroMetrix, Inc. | 21.42 Million USD | -193.926% |
Hyperfine, Inc. | 94.19 Million USD | 33.15% |
Establishment Labs Holdings Inc. | 268.64 Million USD | 76.559% |
Biomerica, Inc. | 9.25 Million USD | -580.484% |
Bone Biologics Corporation | 3.73 Million USD | -1584.751% |
AVITA Medical, Inc. | 144.33 Million USD | 56.372% |
Bluejay Diagnostics, Inc. | 4.86 Million USD | -1193.45% |
Silk Road Medical, Inc | 265.3 Million USD | 76.265% |